Virological and immunological response to Combivir and emergence of drug resistance mutations in a cohort of HIV-2 patients in The Gambia
- 26 June 2006
- journal article
- Published by Wolters Kluwer Health in AIDS
- Vol. 20 (10) , 1455-1458
- https://doi.org/10.1097/01.aids.0000233582.64467.8e
Abstract
Not the final published versioKeywords
This publication has 8 references indexed in Scilit:
- Why Do HIV-1 and HIV-2 Use Different Pathways to Develop AZT Resistance?PLoS Pathogens, 2006
- Natural resistance of human immunodeficiency virus type 2 to zidovudineVirology, 2005
- Highly Active Antiretroviral Therapy and Viral Response in HIV Type 2 InfectionClinical Infectious Diseases, 2004
- Polymorphism and Drug-Selected Mutations in the Protease Gene of Human Immunodeficiency Virus Type 2 from Patients Living in Southern FranceJournal of Clinical Microbiology, 2004
- polGene Sequence Variation in Swedish HIV-2 Patients Failing Antiretroviral TherapyAIDS Research and Human Retroviruses, 2003
- Simple PCR-based Method for Synthesis of Molecular Calibrators and ControlsClinical Chemistry, 2003
- Short Communication:Prevalence of G333D/E in Naive and Pretreated HIV-Infected PatientsAIDS Research and Human Retroviruses, 2002
- Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic MillimeterNew England Journal of Medicine, 1995